These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25349231)

  • 1. DEA reschedules hydrocodone, makes changes to controlled substance disposal.
    Traynor K
    Am J Health Syst Pharm; 2014 Nov; 71(22):1916-8. PubMed ID: 25349231
    [No Abstract]   [Full Text] [Related]  

  • 2. DEA reschedules hydrocodone combination products as schedule II.
    J Mich Dent Assoc; 2014 Oct; 96(10):11. PubMed ID: 25647867
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent issues regarding controlled substances.
    Helgeland D
    S D Med; 2013 Mar; 66(3):105, 107. PubMed ID: 23544298
    [No Abstract]   [Full Text] [Related]  

  • 4. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2014 Aug; 79(163):49661-82. PubMed ID: 25167591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New DEA rules expand options for controlled substance disposal.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):22-6. PubMed ID: 25607591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
    Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
    Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of drug codes for 26 substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2013 Jan; 78(3):664-6. PubMed ID: 23289157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Scheduling of Kratom and Selective Use of Data.
    Griffin OH; Webb ME
    J Psychoactive Drugs; 2018; 50(2):114-120. PubMed ID: 28937941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA to propose hydrocodone reclassification.
    J Calif Dent Assoc; 2014 Jan; 42(1):10. PubMed ID: 25080676
    [No Abstract]   [Full Text] [Related]  

  • 10. Scheduling of new psychoactive substance the Swiss way: A review and critical analysis.
    Grafinger KE; Bernhard W; Weinmann W
    Sci Justice; 2019 Jul; 59(4):459-466. PubMed ID: 31256819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An empty toolbox: hydrocodone to schedule II.
    Berger BJ
    Ann Emerg Med; 2014 Dec; 64(6):19A-21A. PubMed ID: 25606604
    [No Abstract]   [Full Text] [Related]  

  • 12. Rescheduling of combination hydrocodone products: problems for long-term care practitioners.
    Mattingly Ii TJ
    Consult Pharm; 2015 Jan; 30(1):13-9. PubMed ID: 25591027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA advisers support rescheduling of hydrocodone products.
    Traynor K
    Am J Health Syst Pharm; 2013 Mar; 70(5):383-4. PubMed ID: 23413158
    [No Abstract]   [Full Text] [Related]  

  • 14. Rescheduling of hydrocodone combination products.
    Med Lett Drugs Ther; 2014 Oct; 56(1453):101-2. PubMed ID: 25296260
    [No Abstract]   [Full Text] [Related]  

  • 15. DEA expands options for controlled substances disposal.
    J Am Vet Med Assoc; 2014 Nov; 245(9):988. PubMed ID: 25470838
    [No Abstract]   [Full Text] [Related]  

  • 16. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEA reschedules hydrocodone combination products.
    Pergolizzi JV
    Pain Pract; 2015 Feb; 15(2):95-7. PubMed ID: 25639283
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrocodone rescheduling.
    Wroten D
    J Ark Med Soc; 2014 Nov; 111(6):100. PubMed ID: 25654919
    [No Abstract]   [Full Text] [Related]  

  • 19. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
    Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
    J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.